PADI4 and neoplasm: Given that numerous RNA-binding proteins have recently been identified to be targets for both arginine methylation [56,134,135,152,175,176] and PAD-mediated citrullination [157,158], one predicts a similar synergistic effect may be observed in tumours co-treated with PAD and PRMT inhibitors.